Home - Products - GPCR/G Protein - Antibacterial - Cefepime Dihydrochloride Monohydrate

Cefepime Dihydrochloride Monohydrate

CAS No. 123171-59-5

Cefepime Dihydrochloride Monohydrate( Cefepime Hydrochloride | Cefepime HCl | Cefepime hydrochloride monohydrate )

Catalog No. M10913 CAS No. 123171-59-5

Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 35 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cefepime Dihydrochloride Monohydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria.
  • Description
    Cefepime Dihydrochloride Monohydrate is a broad-spectrum cephalosporin with enhanced coverage against Gram-positive and Gram-negative bacteria. (In Vitro):Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics.(In Vivo):Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated.
  • In Vitro
    Cefepime is an extended-spectrum parenteral cephalosporin antibiotic active in vitro against a broad spectrum of gram-positive and gram-negative aerobic bacteria. Cefepime has a decreased propensity to induce beta-lactamases compared with other beta-lactam antibiotics.
  • In Vivo
    Cefepime has a pharmacokinetic disposition similar to that of other renally eliminated cephalosporins, with a half-life of approximately 2 hours. Cefepime has demonstrated clinical efficacy against a variety of infections, including urinary tract infections, pneumonia, and skin and skin structure infections. Cefepime is generally well tolerated.
  • Synonyms
    Cefepime Hydrochloride | Cefepime HCl | Cefepime hydrochloride monohydrate
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    PBPs| Fts1
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    123171-59-5
  • Formula Weight
    571.5
  • Molecular Formula
    C19H24N6O5S2·2HCl·H2O
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4=CSC(=N4)N)SC2)C(=O)O.O.Cl.[Cl-]
  • Chemical Name
    (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;chloride;hydrate;hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Grassi GG, Grassi C. J Antimicrob ChemOthers. 1993 Nov;32 Suppl B:87-94.
molnova catalog
related products
  • Ribocil

    Ribocil is a synthetic mimic of riboflavin 5’-monophosphate (FMN) that competes with the natural ligand to inhibit FMN riboswitch-mediated expression of ribB.

  • ANT431

    ANT431 is a novel potent metallo-β-lactamase (MBL) inhibitor with IC50 of 290 nM and 195 nM for NDM-1 and VIM-2.

  • Buramate

    Buramate is an antipsychotic and anticonvulsant.